
Vanguard Health Care Fund Investor Shares
VGHCX
Updated: 24/09/2026, 01:07:25
For over a quarter-century, this actively managed fund has provided investors with an economical way to access a diverse range of companies operating within the global healthcare industry. Its holdings span various segments, including pharmaceutical developers, medical equipment manufacturers, and groundbreaking research institutions. Compared to other healthcare-focused funds, it generally boasts broader international exposure and tends to have a more stable portfolio with less frequent trading. However, a key consideration for investors is its specialized concentration, as all investments are exclusively confined to the healthcare sector. Given that yearly performance can fluctuate considerably, this fund is best suited as a supplementary component within a broader, well-rounded investment portfolio, especially for those with a long-term outlook.
No summaries found.
- Share price
- $207.98
- Market cap
- $39.77B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 23/05/1984
- Beta
- 0.546
- Last dividend
- $0.00
- Day range
- $207.98 – $211.09
- 52-week range
- $176.37 – $219.84
- 1-day performance
- -1.47%
- 1-year performance
- 17.92%
- Current drawdown (1Y)
- -5.39%
- CIK
- 0000734383
- CUSIP
- 921908307
- ISIN
- US9219083071
- Created
- 07/12/2025, 14:57:52
- Last update
- 24/09/2026, 01:07:25
Track Vanguard Health Care Fund Investor Shares with an AI analyst
See which prediction-market events move VGHCX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.